Hip Fracture
Conditions
Interventions
simple suprainguinal fascia iliaca compartment block :Group A: A single injection of 30 mL of 0.2% ropivacaine hydrochloride will be administered into the fascia iliaca.
simple suprainguinal fascia iliaca compartment block+ obturator nerve block:Group B: As in Group A, with an additional single injection of 15 mL of 0.2% ropivacaine hydrochloride administered into the
simple suprainguinal fascia iliaca compartment block + sacral plexus block:Group C: As in Group A, with an additional single injection of 15 mL of 0.2% ropivacaine hydrochloride administered into the
simple suprainguinal fascia iliaca compartment block + both obturator and sacral plexus blocks:Group D: As in Group A, with additional single injections of 15 mL of 0.2% ropivacaine hydrochloride admi
Sponsors
Sichuan Orthopaedic Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Patients aged 18 to 80 years who are scheduled to undergo primary, unilateral THA via the posterolateral approach under general anesthesia on an elective basis. Eligible patients must have an American Society of Anesthesiologists (ASA) physical status classification of I–III.
Exclusion criteria
Exclusion criteria: Patients will be excluded if they meet any of the following conditions: 1.Lack of informed consent. 2.History of inguinal, supra-inguinal, or sacrococcygeal surgery. 3.Contraindications to the nerve blocks used in this study (e.g., infection at the site of injection, coagulopathy). 4.Lower-limb nerve dysfunction. 5.Allergy to or had contraindications to drugs involved in the study protocol. 6.Cognitive, hearing, or communication disorders that prevent cooperation with study evaluations. 7.Drug or alcohol abuse. 8.Current long-term opioid use (defined as a daily dose >30 mg oral morphine equivalent for more than 30 days). 9.Pregnant or lactating patients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome will be the highest static NRS-11 score recorded during the patient’s stay in the PACU.; | — |
Secondary
| Measure | Time frame |
|---|---|
| Postoperative NRS-11 scores;Rebound pain;Opioid consumption;Postoperative nonopioid analgesic use ;Sensory and motor assessments;Quadriceps femoris muscle strength postoperatively;Athens Insomnia Scale (AIS) ;Hemodynamic parameters;Incidence of delirium;Complications related to nerve block; | — |
Countries
China
Contacts
Public ContactMan Li
Sichuan Orthopaedic Hospital
Outcome results
None listed